In breast cancer survivors, antral follicle count appears to provide data on ovarian function that are independent of antimullerian hormone, FSH, and inhibin B. Therefore, ultrasound appears to be a tool that may not only corroborate, but also add to the accuracy of hormone measures for determining ovarian function in breast cancer survivors. Copyright © 2011 American Society for Reproductive Medicine, Published by Elsevier Inc.
Su, H. I., Chung, K., Sammel, M. D., Gracia, C. R., & Demichele, A. (2011). Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors. Fertility and Sterility, 95(5), 1857–1859. https://doi.org/10.1016/j.fertnstert.2010.12.005